Viewing Study NCT00962832


Ignite Creation Date: 2025-12-24 @ 9:38 PM
Ignite Modification Date: 2026-04-07 @ 7:43 PM
Study NCT ID: NCT00962832
Status: COMPLETED
Last Update Posted: 2016-08-12
First Post: 2009-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus Erythematosus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rhuMAb IFNalpha View
None SLE View